Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2016 | 1 |
2020 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancer.
Expert Opin Investig Drugs. 2016;25(4):393-403. doi: 10.1517/13543784.2016.1153063. Epub 2016 Feb 29.
Expert Opin Investig Drugs. 2016.
PMID: 26863927
Review.
Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.
Rota Scalabrini D, Caravelli D, Carnevale Schianca F, D'Ambrosio L, Tolomeo F, Boccone P, Manca A, De Rosa G, Nuzzo A, Aglietta M, Grignani G.
Rota Scalabrini D, et al. Among authors: nuzzo a.
BMC Res Notes. 2014 Aug 14;7:529. doi: 10.1186/1756-0500-7-529.
BMC Res Notes. 2014.
PMID: 25125318
Free PMC article.
Review.
Item in Clipboard
Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival.
Curcio C, Rosso T, Brugiapaglia S, Guadagnin G, Giordano D, Castellino B, Satolli MA, Spadi R, Campra D, Moro F, Papotti MG, Bertero L, Cassoni P, De Angelis C, Langella S, Ferrero A, Armentano S, Bellotti G, Fenocchio E, Nuzzo A, Ciccone G, Novelli F.
Curcio C, et al. Among authors: nuzzo a.
Clin Exp Med. 2023 Dec;23(8):5089-5100. doi: 10.1007/s10238-023-01236-5. Epub 2023 Nov 1.
Clin Exp Med. 2023.
PMID: 37910256
Free PMC article.
Item in Clipboard
Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study.
Geuna E, Lombardi P, Martinello R, Garino D, Bonzano A, Galizia D, Nuzzo A, Berchialla P, Becco P, Mangioni M, Zarlo L, Montemurro F.
Geuna E, et al. Among authors: nuzzo a.
Cancers (Basel). 2020 Jan 31;12(2):327. doi: 10.3390/cancers12020327.
Cancers (Basel). 2020.
PMID: 32023877
Free PMC article.
Item in Clipboard
Cite
Cite